XORTX Therapeutics Inc. (XRTX)
NASDAQ·Healthcare·Biotechnology
$2.74
-7.74%
Mkt Cap $1.74M
No analyst coverage available
We don't have analyst ratings or price target data for XORTX Therapeutics Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.